The fecal bacterial microbiota is not useful for discriminating between lymphoplasmacytic enteritis and low-grade intestinal T-cell lymphoma in cats, nor for predicting therapeutic response

OBJECTIVE To evaluate the fecal bacterial microbiota at the time of diagnosis (T0) and after one month of therapy (T1) in cats diagnosed with lymphoplasmacytic enteritis (LPE) or cats with low-grade intestinal T-cell lymphoma (LGITL) and to compare these findings with those of healthy cats ANIMALS 5 healthy cats, 13 cats with LPE and 7 cats with LGITL were prospectively enrolled between June 2020 and June 2021 METHODS Fecal samples were collected at T0 and T1 and DNA was extracted for 16S ribosomal amplicon sequencing. Alpha- and Beta-diversity were computed. The taxonomic assignment was performed using sequences from the Silva v138 formatted reference database. Differential abundant taxa were selected in each taxonomic level, with the P value adjusted <0.05, as cut-off RESULTS No significant differences in alpha- and beta-diversity were found either at T0 or T1 between healthy and diseased cats, nor between cats with LPE and LGITL. Beta-diversity analysis showed an increase in the Fusobacteriaceae family in cats with LGITL at T0, compared to cats with LPE. Regardless of histological diagnosis, several microbiota differences were found at T0 based on serum cobalamin levels CLINICAL RELEVANCE Fecal samples were successfully used to characterize the bacteriome of the intestinal tract in cats by 16S rRNA gene sequencing. However, results highlighted that the metagenomic evaluation was not useful to discriminate between LPE and LGITL, nor to predict the therapeutic response in this study population